OPRX - OptimizeRx EPS misses by $0.04 misses on revenue February, 27 2020 04:10 PM OptimizeRx Corporation OptimizeRx (NASDAQ:OPRX): Q4 Non-GAAP EPS of -$0.03 misses by $0.04; GAAP EPS of -$0.14 misses by $0.03.More news on: OptimizeRx Corporation, Earnings news and commentary, Consumer stocks news, , Read more ...